Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori

References

1. Best L. M., Haldane D. J. M., Keelan M., Taylor D. E., Thomson A. B. R., Loo V., Fallone C. A., Lyn P., Smaill F. M. other authors 2003; Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. Antimicrob Agents Chemother 47:3138–3144 [CrossRef]
   [Google Scholar]
2. Bina J. E., Alm R. A., Uria-Nickelsen M., Thomas S. R., Trust T. J., Hancock R. E. 2000; Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob Agents Chemother 44:248–254 [CrossRef]
   [Google Scholar]
3. Chopra I., Roberts M. 2001; Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65:232–260 [CrossRef]
   [Google Scholar]
4. Dailidiene D., Bertoli M. T., Miciuleviciene J., Mukhopadhyay A. K., Dailide G., Pascasio M. A., Kupcinkas L., Berg D. E. 2002; Emergence of tetracycline resistance in Helicobacter pylori : multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother 46:3940–3946 [CrossRef]
   [Google Scholar]
5. Falsafi T., Valizadeh N., Najafi M., Ehsani A., Khani A., Landarani Z., Falahi Z. 2007; Culture of Helicobacter pylori from stool samples in children. Can J Microbiol 53:411–416 [CrossRef]
   [Google Scholar]
6. Falsafi T., Favaedi R., Mahjoub F., Najafi M. 2009; Application of stool-PCR test for diagnosis of Helicobacter pylori infection in children. World J Gastroenterol 15:484–488 [CrossRef]
   [Google Scholar]
7. Glocker E., Berning M., Gerrits M. M., Kusters J. G., Kist M. 2005; Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori . Antimicrob Agents Chemother 49:3166–3170 [CrossRef]
   [Google Scholar]
8. Graham D. Y., Qureshi W. A. 2000; Antibiotic-resistant H. pylori infection and its treatment. Curr Pharm Des 6:1537–1544 [CrossRef]
   [Google Scholar]
9. Kim J. J., Reddy R., Lee M., Kim J. G., El-Zaatari F. A., Osato M. S., Graham D. Y. 2001; Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother 47:459–461 [CrossRef]
   [Google Scholar]
10. King A. 2001; Recommendations for susceptibility tests on fastidious organisms and those requiring special handling. J Antimicrob Chemother 48 (Suppl. S1):77–80 [CrossRef]
    [Google Scholar]
11. Kutschke A., de Jonge B. L. M. 2005; Compound efflux in Helicobacter pylori . Antimicrob Agents Chemother 49:3009–3010 [CrossRef]
    [Google Scholar]
12. Kwon D. H., Kim J. J., Lee M., Yamaoka Y., Kato M., Osato M. S., El-Zaatari F. A. K., Graham D. Y. 2000; Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori . Antimicrob Agents Chemother 44:3203–3205 [CrossRef]
    [Google Scholar]
13. Lawson A. J., Elviss N. C., Owen R. J. 2005; Real-time PCR detection and frequency of 16S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales. J Antimicrob Chemother 56:282–286 [CrossRef]
    [Google Scholar]
14. Li Y., Dannelly H. K. 2006; Inactivation of the putative tetracycline resistance gene HP1165 in Helicobacter pylori led to loss of inducible tetracycline resistance. Arch Microbiol 185:255–262 [CrossRef]
    [Google Scholar]
15. Lin J., Michel L. O., Zhang Q. 2002; CmeABC functions as a multidrug efflux system in Campylobacter jejuni . Antimicrob Agents Chemother 46:2124–2131 [CrossRef]
    [Google Scholar]
16. Loffeld R. J., Fijen C. A. 2003; Antibiotic resistance of Helicobacter pylori : a cross-sectional study in consecutive patients, and relation to ethnicity. Clin Microbiol Infect 9:600–604 [CrossRef]
    [Google Scholar]
17. McNulty C., Owen R., Tompkins D., Hawtin P., McColl K., Price A., Smith G., Teare L. 2002; Helicobacter pylori susceptibility testing by disk diffusion. J Antimicrob Chemother 49:601–609 [CrossRef]
    [Google Scholar]
18. Mendonca S., Ecclissato C., Sartori M. S., Goday A. P., Guerrzont R. A., Degger M., Predrazzoli J. Jr 2000; Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 5:79–83 [CrossRef]
    [Google Scholar]
19. Nikaido H. 1998; Antibiotic resistance caused by Gram-negative multidrug efflux pumps. Clin Infect Dis 27:S32–S41 [CrossRef]
    [Google Scholar]
20. Nonaka L., Connell S. R., Taylor D. E. 2005; 16S rRNA mutations that confer tetracycline resistance in Helicobacter pylori decrease drug binding in Escherichia coli ribosomes. J Bacteriol 187:3708–3712 [CrossRef]
    [Google Scholar]
21. Osato M. S. R., Reddy S. G., Penland R. I., Malaty H. M., Graham D. Y. 2001; Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromucin in the United States. Arch Intern Med 161:1217–1220 [CrossRef]
    [Google Scholar]
22. Trieber C. A., Taylor D. E. 2002; Mutations in the 16SrRNA genes of Helicobacter pylori mediate resistance to tetracycline. J Bacteriol 184:2131–2140 [CrossRef]
    [Google Scholar]
23. van Amsterdam K., Bart A., Ende A. 2005; A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob Agents Chemother 49:1477–1482 [CrossRef]
    [Google Scholar]
24. Wu H., Shi X. D., Wang H. T., Liu J. X. 2000; Resistance of Helicobacter pylori to metronidazole, tetracycline and amoxycillin. J Antimicrob Chemother 46:121–123 [CrossRef]
    [Google Scholar]
25. Wu J. Y., Kim J. J., Reddy K. R., Wang W. M., Graham D. Y. 2005; Tetracycline-resistant clinical H. pylori isolates with and without mutations in 16rRNA-encoding genes. Antimicrob Agents Chemother 49:578–583 [CrossRef]
    [Google Scholar]